Gram Positive Bacterial Infections Completed Phase 2 Trials for Vancomycin (DB00512)

Also known as: Gram Positive Bacterial Infection / Infections, Gram-Positive Bacterial / Gram-positive Bacterial Infection / Gram-Positive Bacterial Infections / Bacterial infectious disease (disorder) / Bacterial infection / Bacterial Infections / Bacterial infection of unspecified site / Bacterial infection by site (disorder) / Bacterial infectious disorders / Bacterial infection NOS (disorder) / Bacterial infection NOS / Infection bacterial / Bacterial diseases NOS / Bacterial diseases NOS (disorder) / Bacterial diseases (& [excl TB]) / Bacterial infection, unspecified / [X]Bacterial infection, unspecified (disorder)

IndicationStatusPhase
DBCOND0070817 (Gram Positive Bacterial Infections)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061633Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)Treatment
NCT00077675Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)Treatment
NCT03964493TNP-2092 to Treat Acute Bacterial Skin and Skin Structure InfectionTreatment
NCT00062647Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaTreatment